e-150 Search Results


alomone tamapin  (Alomone Labs)
94
Alomone Labs alomone tamapin
a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
Alomone Tamapin, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e-150/bio_rxiv__64898__2026__03__19__712770-257-0-0?v=Alomone+Labs
Average 94 stars, based on 1 article reviews
alomone tamapin - by Bioz Stars, 2026-08
94/100 stars
  Buy from Supplier
praestor e-150  (DeGussa Corporation)
90
DeGussa Corporation praestor e-150
a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
Praestor E 150, supplied by DeGussa Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e-150/us09903069-163-23-8?v=DeGussa+Corporation
Average 90 stars, based on 1 article reviews
praestor e-150 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
epoxy diacrylate crosslinking agent cnuv e150/80  (Sartomer USA LLC)
90
Sartomer USA LLC epoxy diacrylate crosslinking agent cnuv e150/80
a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
Epoxy Diacrylate Crosslinking Agent Cnuv E150/80, supplied by Sartomer USA LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e-150/us10633499-313-8-17?v=Sartomer+USA+LLC
Average 90 stars, based on 1 article reviews
epoxy diacrylate crosslinking agent cnuv e150/80 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
e150  (Blackwell Verlag)
90
Blackwell Verlag e150
a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
E150, supplied by Blackwell Verlag, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e-150/pm20042058-46-1-4?v=Blackwell+Verlag
Average 90 stars, based on 1 article reviews
e150 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
newport breeze e150 ventilator  (Newport Medical Instruments Inc)
90
Newport Medical Instruments Inc newport breeze e150 ventilator
a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
Newport Breeze E150 Ventilator, supplied by Newport Medical Instruments Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e-150/pm12458614-151-32-37?v=Newport+Medical+Instruments+Inc
Average 90 stars, based on 1 article reviews
newport breeze e150 ventilator - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
ph meter metrohm herisau e150  (Metrohm AG)
90
Metrohm AG ph meter metrohm herisau e150
a-b Representative ventral root recordings showing the effect of the broad-spectrum SK <t>activator</t> <t>1-EBIO</t> ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor <t>tamapin</t> ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.
Ph Meter Metrohm Herisau E150, supplied by Metrohm AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/e-150/pm15246438-70-7-8?v=Metrohm+AG
Average 90 stars, based on 1 article reviews
ph meter metrohm herisau e150 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
r777-e150 hs.pak2-nostop (plasmid #70434)  (Addgene inc)
N/A
Standard format: Plasmid sent in bacteria as agar stab
   Buy from Supplier

Image Search Results


a-b Representative ventral root recordings showing the effect of the broad-spectrum SK activator 1-EBIO ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor tamapin ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.

Journal: bioRxiv

Article Title: SK2/3 CHANNELS COUPLE WITH T-TYPE CA 2+ CHANNELS TO GATE SPINAL LOCOMOTOR RHYTHM GENERATION

doi: 10.64898/2026.03.19.712770

Figure Lengend Snippet: a-b Representative ventral root recordings showing the effect of the broad-spectrum SK activator 1-EBIO ( a ; 5 mM) and the SK2/3-selective activator CyPPA ( b ; 0.3-0.4 mM) on ongoing fictive locomotion induced by NMDA/5-HT (5/10 µM). Top left in a and b : Schematic of the isolated spinal cord preparation illustrating focal drug puff application onto rhythmogenic segments (L 1 -L 2 ) and bilateral L5 ventral root recordings (L5R, L5L). Bottom: Raw ventral root activity (black) superimposed with low-pass filtered envelopes (blue for 1-EBIO, orange for CyPPA); vertical arrows indicate puff onset. Top right: Expanded time windows ( a’ , b’ ) of the recordings shown below, highlighting rhythm suppression. c-d Representative recordings showing the induction of locomotor-like activity in quiescent preparations (subliminal NMDA/5-HT: 0-1/10 µM) by the SK2/3 inhibitor tamapin ( c ; 1 µM) or the T-type calcium channel blocker nickel ( d ; 10-20 µM). The experimental layout and display are identical to a, b . Low-pass filtered envelopes are shown in purple (tamapin) and teal (nickel). Arrows indicate puff onset.

Article Snippet: Alomone: tamapin (5-10 nM), 1-EBIO (200 μM), CyPPA (1-10 μM), and Tram-34 (5 μM).

Techniques: Isolation, Activity Assay